Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo

Authors

See-Hyoung Park, Standford University School of Medicine
Young Min Chung, Stanford University School of Medicine
Jessica Ma, Stanford University School of Medicine
Qin Yang, Washington University School of Medicine in St. Louis
Jonathan S. Berek, Stanford University School of Medicine
Mickey C-T Hu, Stanford University School of Medicine

Journal

Oncotarget

Publication Date

2016

Volume

7

Issue

27

Inclusive Pages

42110-42125

Document Type

Open Access Publication

DOI

10.18632/oncotarget.9881

Rights and Permissions

See-Hyoung Park, et al. Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo. 2016. Oncotarget 7(27): 42110-42125. doi: 10.18632/oncotarget.9881. Copyright: © Park et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Park, See-Hyoung; Chung, Young Min; Ma, Jessica; Yang, Qin; Berek, Jonathan S.; and Hu, Mickey C-T, "Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo." Oncotarget. 7, 27. 42110-42125. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/6481